Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20265 analyst targets · 90 days
- Share price
- $23.40
- Average 1Y price target
- $61.00+160.68%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity3
- P/E1
- P/B2
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 1 | $56.00 |
| Last quarter | 5 | $60.80 |
| Last year | 27 | $56.30 |
| All time | 44 | $65.14 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 9, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Oct 8, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Sep 30, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 11, 2026 | Barclays | maintain | Overweight | Overweight |
| Sep 4, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 12, 2026 | TD Cowen | maintain | Hold | Hold |
| Aug 12, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Aug 12, 2026 | Oppenheimer | downgrade | Outperform | Perform |
| Aug 12, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Aug 12, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 28, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jul 27, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 24, 2026 | UBS | downgrade | Buy | Neutral |
| Jul 7, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jun 3, 2026 | UBS | maintain | Buy | Buy |
| Jun 3, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 18, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 13, 2026 | TD Cowen | maintain | Hold | Hold |
| May 13, 2026 | RBC Capital | maintain | Outperform | Outperform |
| May 13, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Apr 21, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Apr 15, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 11, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Mar 11, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 4, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 22, 2026 | TD Cowen | downgrade | Buy | Hold |
| Jan 22, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 20, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Dec 17, 2025 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Dec 12, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Dec 8, 2025 | UBS | maintain | Buy | Buy |
| Nov 13, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Nov 13, 2025 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Nov 13, 2025 | Barclays | maintain | Overweight | Overweight |
| Oct 17, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Oct 9, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Aug 25, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Aug 12, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Aug 12, 2025 | Morgan Stanley | maintain | Overweight | Overweight |